1. 502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab. (4th December 2021) Authors: Gupta, Anil K; Rojas, Yaneicy Gonzalez; Juarez, Erick; Casal, Manuel Crespo; Moya, Jaynier; Falci, Diego Rodrigues; Sarkis, Elias H; Solis, Joel; Zheng, Hanzhe; Scott, Nicola; Cathcart, Andrea L; Hebner, Christy; Sager, Jennifer; Mogalian, Erik; Austin, Daren; Peppercorn, Amanda; Alexander, Eliza... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Issue 1 (January 2021) Authors: Heaney, Liam G; Busby, John; Hanratty, Catherine E; Djukanovic, Ratko; Woodcock, Ashley; Walker, Samantha M; Hardman, Timothy C; Arron, Joseph R; Choy, David F; Bradding, Peter; Brightling, Christopher E; Chaudhuri, Rekha; Cowan, Douglas C; Mansur, Adel H; Fowler, Stephen J; Niven, Robert M; Howa... Journal: Lancet Issue: Volume 9:Issue 1(2021) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022) Authors: Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗